Open Access
REVIEW
HAISU LIANG1,2,#, WEI YAN3,#, ZHI LIU1,4, YUNBO HE1,2,5, JIAO HU1, ZHIWEI SHU1, HUIHUANG LI1, BELAYDI OTHMANE1, WENBIAO REN1,6, CHAO QUAN1, DONGXU QIU1, MINFENG CHEN1, WEI XIONG5, BINGNAN ZHANG1,*, PEIHUA LIU1,2,*
1 Department of Urology, Xiangya Hospital, Central South University, Changsha, 410000, China
2 National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410000, China
3 Department of Urology, Shimen Hospital of TCM, Changde, 415300, China
4 Department of Urology, The Second Affiliated Hospital, Guizhou Medical University, Kaili, 556000, China
5 NHC Key Laboratory of Carcinogenesis, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China
6 George Whipple Lab for Cancer Research, University of Rochester Medical Institute, Rochester, NY 14627, USA
* Corresponding Author: BINGNAN ZHANG. Email: ; PEIHUA LIU. Email:
# These two authors contributed equally to this work
Oncology Research https://doi.org/10.32604/or.2024.054623
Received 03 June 2024; Accepted 13 November 2024; Published online 04 December 2024
View
Download
Like
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma
Fangjin Lu, Bin Mu, Ge Jin, Lin...Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations
Yudie Yang, Xia Zhang, Yajie Gao,...